Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Complementary DNA Stories

2014-02-06 08:28:21

PALO ALTO, Calif., Feb. 6, 2014 /PRNewswire/ -- Cellular Research, Inc., today announced that its Molecular Indexing(TM) technology enables the absolute quantification of the starting copy number of an expressed gene, or RNA transcript, in an RNA sequencing (RNA-Seq) library. Data were published in the February 4, 2014 print edition of the Proceedings of the National Academy of Sciences (PNAS), and the article is currently available online. RNA-Seq has become an extremely important...

2013-10-21 12:27:30

MOUNTAIN VIEW, Calif., Oct. 21, 2013 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the launch of the SMARTer Stranded RNA-Seq Kit for strand-specific RNA-Seq from low-input RNA samples. This kit integrates Illumina® library preparation with SMART(TM) cDNA amplification to create indexed libraries in less than four hours and provides high-quality stranded data, with greater than 99% accuracy in strand identification. (Logo:...

2013-06-20 08:27:31

PISCATAWAY, N.J., June 20, 2013 /PRNewswire/ -- On June 13, 2013, the United States Supreme Court unanimously ruled that although isolated, natural gene sequences are unpatentable, cDNA (referred to as synthetic DNA) is officially considered patentable subject material. The ruling was issued after the court reviewed patents owned by Myriad Genetics Inc. in the high-profile case Association for Molecular Pathology v. Myriad Genetics. The patents claimed the genes BRCA1 and BRCA2, as well as...

2013-06-13 16:27:09

TUCSON, Ariz., June 13, 2013 /PRNewswire-USNewswire/ -- The Association of American Physicians & Surgeons (AAPS) applauds the U.S. Supreme Court for declining to issue a sweeping ruling today against the patentability of DNA material in Ass'n for Molecular Pathology v. Myriad Genetics, Inc., Sup. Ct. No. 12-398. Instead, the Supreme Court acknowledged the immense value of patents to encourage medical innovation, and fully upheld the patentability of cDNA, which is synthetic DNA similar to...

2013-06-03 23:17:40

Scientists from Peking University, China and OriGene Technologies jointly published that multiple lineage specifier genes can replace OCT4 and SOX2, the core regulators of cell pluripotency. The results were published in the May 23rd issue of Cell, titled “Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers”. Rockville, MD (PRWEB) June 03, 2013 Scientists from Peking University, China and OriGene Technologies jointly published that multiple lineage specifier...

2012-01-31 10:19:57

Researchers at the RIKEN Omics Science Center (OSC) have developed a robotic workflow for sample preparation on the HeliScope single molecule sequencer which drastically reduces sample preparation time to from 42 days to only 8 days. The workflow uses Cap Analysis of Gene Expression (CAGE), a unique method developed at the OSC for determining transcriptional starting sites in the genome and their expression levels. A key obstacle in DNA sequencing is the long time required for sample...

2009-11-09 12:48:00

ROCKVILLE, Md., Nov. 9 /PRNewswire/ -- OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics. "Generating high quality mono-specific antibodies in a high throughput manner is critical for the success of...

2009-08-24 10:28:00

ROCKVILLE, Md., Aug. 24 /PRNewswire / --OriGene Technologies, Inc. announces the release of 5,000 purified human proteins, representing the most comprehensive offering of human cell-produced human proteins. OriGene's recombinant proteins are purified from HEK293 cells transiently transfected with TrueORF cDNA clones. Mammalian cell expressed proteins are superior to other expression systems in that it produces proteins with the most authentic protein structure, post-translational...

2009-03-17 11:29:50

Researchers at the University of Pennsylvania School of Medicine have identified a master switch that might prevent cancer cells from metastasizing from a primary tumor to other organs. The switch is a protein that, when in the "on" position, maintains the normal character of cells that line the surface of organs and body cavities. These epithelial cells are the type of cell from which most solid tumors arise. However, when the switch is turned "off" or absent, epithelial cells acquire...